AAV-Ligand Conjugates for Improved Efficacy & Biodistribution in CNS
Time: 2:30 pm
day: Day One: Track A PM
Details:
- AAV capsids from 1st and last generations limitations (efficiency and safety) are related to the nature of the capsid composition
- Chemical conjugation of AAV capsid alter dramatically the biology of AAV leading to improve bio distribution, transduction and immunological profile
- Chemical conjugation of AAV is a versatile and scalable new capsid technology
